Bertholt Leeftink is the Managing Director of Oncode Institute, responsible for strategy, governance, and valorization at Oncode Institute — three core areas essential to shaping the organisation’s future. His appointment reflects Oncode’s ambition to further integrate science and impact in the years ahead. Leeftink brings a proven track record at the intersection of government, innovation, and business.

He previously served as CEO of NRG PALLAS, a global leader in the production of medical isotopes (2019–2024), and was Director-General for Enterprise and Innovation at the Ministry of Economic Affairs and Climate Policy. In this role, he played an instrumental part in the founding of Oncode Institute in 2017. Leeftink is a strong advocate for public-private partnerships, has been closely involved in creating Invest-NL, and brings broad experience across the life sciences sector and beyond. He holds a PhD in economics from the University of Amsterdam.